Wed 4/1/2020 11:34 ET
DJIA21326.47575.812.70%TELCO157.122.471.57%GOLD1598.501.920.12%Shanghai2734.5215.590.57%
S&P 5002506.2875.943.03%BANKS287.2516.785.84%OIL20.520.040.19%BITCOIN6274.79154.362.46%
NASDAQ7515.90179.632.39%PHARM539.5810.631.97%US/EU1.090.000.01%Futures2498.3871.452.86%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  
From: Sqwii (Rep: 389)Date: 05/11/2012 03:47
Forum: Neurocrine Biosciences - Msg #1077Thread #673400691 (Rec: 0)
NBIX another one I like here at 6.96$ for some news coming near term this month



Urocortin 2 Update
The Christchurch Cardioendocrine Research Group at University of Otago, Christchurch School of Medicine and Health Sciences, New Zealand, in collaboration with the Company, is conducting a Phase II study of urocortin 2 in acute decompensated heart failure patients. This study is now complete and top-line results are expected shortly.

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.



Started my own blog www.SqwiiTrader.com

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Sqwii: Reward | Watch | IgnoreNBIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.